Skip to main content
TipRanks
Go Ultimate75% OFF

Ping An Biomedical (PASW) Stock Statistics & Valuation Metrics

18 Followers

Total Valuation

Ping An Biomedical has a market cap or net worth of $3.99M. The enterprise value is $9.30T.

Market Cap
$3.99M
Enterprise Value
$9.30T

Share Statistics

Ping An Biomedical has 2,821,675 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding
2,821,675
Owned by Insiders
―
Owned by Institutions
0.20%

Financial Efficiency

Ping An Biomedical’s return on equity (ROE) is -0.28 and return on invested capital (ROIC) is -23.05%.

Return on Equity (ROE)
-0.28
Return on Assets (ROA)
-0.19
Return on Invested Capital (ROIC)
-23.05%
Return on Capital Employed (ROCE)
-0.32
Revenue Per Employee
4.88M
Profits Per Employee
-1.83M
Employee Count
7
Asset Turnover
0.50
Inventory Turnover
75.13

Valuation Ratios

The current PE Ratio of Ping An Biomedical is -0.63. Ping An Biomedical’s PEG ratio is 0.01.

PE Ratio
-0.63
PS Ratio
1.02
PB Ratio
0.15
Price to FCF
-4.68
Price to Operating Cash Flow
-2.10
PEG Ratio
0.01

Income Statement

In the last 12 months, Ping An Biomedical had revenue of 34.15M and earned -12.83M in profits. Earnings per share was -27.60.

Revenue
34.15M
Gross Profit
949.50K
Operating Income
-14.70M
Pretax Income
-14.68M
Net Income
-12.83M
EBITDA
-14.37M
Earnings Per Share (EPS)
-27.60

Cash Flow

In the last 12 months, operating cash flow was -5.54M and capital expenditures 0, giving a free cash flow of -5.54M billion.

Operating Cash Flow
-5.54M
Free Cash Flow
-5.54M
Free Cash Flow per Share
-4.39

Dividends & Yields

Ping An Biomedical pays an annual dividend of ―, resulting in a dividend yield of ―

Dividend Per Share
―
Dividend Yield
―
Payout Ratio
N/A
Free Cash Flow Yield
-20.83%
Earnings Yield
-31.66%

Stock Price Statistics

Beta
1.74
52-Week Price Change
-93.98%
50-Day Moving Average
4.49
200-Day Moving Average
5.75
Relative Strength Index (RSI)
31.09
Average Volume (3m)
185.84K

Financial Position

Ping An Biomedical as a current ratio of 2.76, with Debt / Equity ratio of 23.14%

Current Ratio
2.76
Quick Ratio
2.74
Debt to Market Cap
0.06
Net Debt to EBITDA
-0.65
Interest Coverage Ratio
-47.88

Taxes

In the past 12 months, Ping An Biomedical has paid -1.86M in taxes.

Income Tax
-1.86M
Effective Tax Rate
0.13

Enterprise Valuation

Ping An Biomedical EV to EBITDA ratio is -2.85, with an EV/FCF ratio of -5.42.

EV to Sales
1.18
EV to EBITDA
-2.85
EV to Free Cash Flow
-5.42
EV to Operating Cash Flow
-5.42

Balance Sheet

Ping An Biomedical has $6.84M in cash and marketable securities with $10.27M in debt, giving a net cash position of -$3.43M billion.

Cash & Marketable Securities
$6.84M
Total Debt
$10.27M
Net Cash
-$3.43M
Net Cash Per Share
-$1.22
Tangible Book Value Per Share
$61.90

Margins

Gross margin is 9.27%, with operating margin of -41.34%, and net profit margin of -14.78%.

Gross Margin
9.27%
Operating Margin
-41.34%
Pretax Margin
-18.28%
Net Profit Margin
-14.78%
EBITDA Margin
-41.32%
EBIT Margin
-41.34%

Analyst Forecast

The average price target for Ping An Biomedical is ―, which is 11.43% higher than the current price. The consensus rating is ―

Price Target
―
Price Target Upside
―
Analyst Consensus
―
Analyst Count
0
Revenue Growth Forecast
―
EPS Growth Forecast
―